These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)]. Vasconez F, Pérez-Garcia R, Olivas E, Bolívar JE, Valderrábano F. Med Clin (Barc); 1980 Dec 15; 75(10):430-4. PubMed ID: 7464329 [Abstract] [Full Text] [Related]
7. Pseudohyperaldosteronism due to application of an antihemorrhoid cream. Marin F, González Quintela A, Moya M, Suárez E, de Zárraga M. Nephron; 1989 Dec 15; 52(3):281-2. PubMed ID: 2739869 [Abstract] [Full Text] [Related]
13. Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. Vita G, Bartolone S, Santoro M, Toscano A, Carrozza G, Girlanda P, Frisina N. Clin Neuropathol; 1987 Dec 15; 6(2):80-5. PubMed ID: 3594977 [Abstract] [Full Text] [Related]
14. [Hypermineralocorticism secondary to the topical use of corticoids]. Rama H, Carreras L, Martínez-Amenos A, Sarrias X. Rev Clin Esp; 1987 Dec 15; 174(3-4):111-4. PubMed ID: 6515071 [No Abstract] [Full Text] [Related]
15. [Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone]. Virgolini L, Geatti O, Giunta G. Minerva Cardioangiol; 1984 Dec 15; 32(7-8):473-5. PubMed ID: 6208510 [No Abstract] [Full Text] [Related]
16. Hypokalemic rhabdomyolysis secondary to pseudohyperaldosteronism due to the use of a lotion containing 9-alpha-fluoroprednisolone. Mijares RP. Nephron; 1986 Dec 15; 43(3):232-3. PubMed ID: 3724933 [No Abstract] [Full Text] [Related]
17. Pseudoprimary aldosteronism from the topical application of 9-alpha-fluorprednisolone to the skin. Montoliu J, Botey A, Trilla A, Revert L. Clin Nephrol; 1984 Nov 15; 22(5):262-6. PubMed ID: 6394185 [Abstract] [Full Text] [Related]